Logo image of FTCH

FARFETCH LTD-CLASS A (FTCH) Stock Fundamental Analysis

NYSE:FTCH - New York Stock Exchange, Inc. - KY30744W1070 - Common Stock - Currency: USD

0.6428  -0.1 (-13.26%)

Premarket: 0.42 -0.22 (-34.66%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to FTCH. FTCH was compared to 121 industry peers in the Specialty Retail industry. FTCH may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, FTCH is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

FTCH had negative earnings in the past year.
In the past year FTCH has reported a negative cash flow from operations.
In multiple years FTCH reported negative net income over the last 5 years.
In the past 5 years FTCH reported 4 times negative operating cash flow.
FTCH Yearly Net Income VS EBIT VS OCF VS FCFFTCH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 1B -1B -2B -3B

1.2 Ratios

FTCH's Return On Assets of -25.42% is on the low side compared to the rest of the industry. FTCH is outperformed by 83.97% of its industry peers.
Looking at the Return On Equity, with a value of -193.07%, FTCH is doing worse than 80.15% of the companies in the same industry.
Industry RankSector Rank
ROA -25.42%
ROE -193.07%
ROIC N/A
ROA(3y)-14.91%
ROA(5y)-14.88%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FTCH Yearly ROA, ROE, ROICFTCH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 500 1K 1.5K

1.3 Margins

FTCH has a better Gross Margin (42.89%) than 70.23% of its industry peers.
FTCH's Gross Margin has declined in the last couple of years.
FTCH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.89%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.65%
GM growth 5Y-3.6%
FTCH Yearly Profit, Operating, Gross MarginsFTCH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 50 -50 -100 -150

More info and screens

2

2. Health

2.1 Basic Checks

FTCH does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, FTCH has more shares outstanding
Compared to 1 year ago, FTCH has a worse debt to assets ratio.
FTCH Yearly Shares OutstandingFTCH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M
FTCH Yearly Total Debt VS Total AssetsFTCH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 1B 2B 3B

2.2 Solvency

FTCH has an Altman-Z score of -0.30. This is a bad value and indicates that FTCH is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.30, FTCH is doing worse than 83.21% of the companies in the same industry.
FTCH has a Debt/Equity ratio of 2.41. This is a high value indicating a heavy dependency on external financing.
FTCH has a Debt to Equity ratio of 2.41. This is in the lower half of the industry: FTCH underperforms 71.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.41
Debt/FCF N/A
Altman-Z -0.3
ROIC/WACCN/A
WACC4.98%
FTCH Yearly LT Debt VS Equity VS FCFFTCH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 500M -500M 1B -1B -1.5B

2.3 Liquidity

FTCH has a Current Ratio of 1.47. This is a normal value and indicates that FTCH is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.47, FTCH perfoms like the industry average, outperforming 51.91% of the companies in the same industry.
A Quick Ratio of 1.02 indicates that FTCH should not have too much problems paying its short term obligations.
FTCH's Quick ratio of 1.02 is fine compared to the rest of the industry. FTCH outperforms 72.52% of its industry peers.
Industry RankSector Rank
Current Ratio 1.47
Quick Ratio 1.02
FTCH Yearly Current Assets VS Current LiabilitesFTCH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 500M 1B 1.5B 2B

More info and screens

5

3. Growth

3.1 Past

FTCH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -108.06%.
FTCH shows a small growth in Revenue. In the last year, the Revenue has grown by 0.37%.
FTCH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 43.11% yearly.
EPS 1Y (TTM)-108.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-204.76%
Revenue 1Y (TTM)0.37%
Revenue growth 3Y31.41%
Revenue growth 5Y43.11%
Sales Q2Q%-1.24%

3.2 Future

The Earnings Per Share is expected to grow by 21.33% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 12.49% on average over the next years. This is quite good.
EPS Next Y-76.96%
EPS Next 2Y-17.65%
EPS Next 3Y-1.08%
EPS Next 5Y21.33%
Revenue Next Year7.53%
Revenue Next 2Y14.78%
Revenue Next 3Y14.71%
Revenue Next 5Y12.49%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
FTCH Yearly Revenue VS EstimatesFTCH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
FTCH Yearly EPS VS EstimatesFTCH Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -2 -4 -6 -8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

FTCH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year FTCH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FTCH Price Earnings VS Forward Price EarningsFTCH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FTCH Per share dataFTCH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-17.65%
EPS Next 3Y-1.08%

More info and screens

0

5. Dividend

5.1 Amount

FTCH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FARFETCH LTD-CLASS A

NYSE:FTCH (12/15/2023, 8:04:00 PM)

Premarket: 0.42 -0.22 (-34.66%)

0.6428

-0.1 (-13.26%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)08-17 2023-08-17/amc
Earnings (Next)12-28 2023-12-28/amc
Inst Owners0.04%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap226.66M
Analysts68.8
Price Target4.59 (614.06%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.62%
Min EPS beat(2)-49.04%
Max EPS beat(2)64.29%
EPS beat(4)3
Avg EPS beat(4)19.54%
Min EPS beat(4)-49.04%
Max EPS beat(4)64.29%
EPS beat(8)7
Avg EPS beat(8)26.09%
EPS beat(12)9
Avg EPS beat(12)-144.11%
EPS beat(16)11
Avg EPS beat(16)-123.02%
Revenue beat(2)1
Avg Revenue beat(2)-3.6%
Min Revenue beat(2)-13.6%
Max Revenue beat(2)6.39%
Revenue beat(4)1
Avg Revenue beat(4)-2.72%
Min Revenue beat(4)-13.6%
Max Revenue beat(4)6.39%
Revenue beat(8)2
Avg Revenue beat(8)-3.02%
Revenue beat(12)6
Avg Revenue beat(12)0.1%
Revenue beat(16)10
Avg Revenue beat(16)1.7%
PT rev (1m)-8.89%
PT rev (3m)-32.77%
EPS NQ rev (1m)5.81%
EPS NQ rev (3m)6.75%
EPS NY rev (1m)4.21%
EPS NY rev (3m)3.46%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)98831%
Revenue NY rev (1m)-0.2%
Revenue NY rev (3m)-0.35%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.1
P/FCF N/A
P/OCF N/A
P/B 0.49
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.29
EYN/A
EPS(NY)-1.3
Fwd EYN/A
FCF(TTM)-1.25
FCFYN/A
OCF(TTM)-0.7
OCFYN/A
SpS6.67
BVpS1.31
TBVpS-2.96
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -25.42%
ROE -193.07%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.89%
FCFM N/A
ROA(3y)-14.91%
ROA(5y)-14.88%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.65%
GM growth 5Y-3.6%
F-Score2
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 2.41
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 55.05%
Cap/Sales 8.16%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.47
Quick Ratio 1.02
Altman-Z -0.3
F-Score2
WACC4.98%
ROIC/WACCN/A
Cap/Depr(3y)61.75%
Cap/Depr(5y)118.22%
Cap/Sales(3y)7.77%
Cap/Sales(5y)9.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-108.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-204.76%
EPS Next Y-76.96%
EPS Next 2Y-17.65%
EPS Next 3Y-1.08%
EPS Next 5Y21.33%
Revenue 1Y (TTM)0.37%
Revenue growth 3Y31.41%
Revenue growth 5Y43.11%
Sales Q2Q%-1.24%
Revenue Next Year7.53%
Revenue Next 2Y14.78%
Revenue Next 3Y14.71%
Revenue Next 5Y12.49%
EBIT growth 1Y-43.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year99.77%
EBIT Next 3Y34.01%
EBIT Next 5Y25.35%
FCF growth 1Y-44.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-44.15%
OCF growth 3YN/A
OCF growth 5YN/A